Pacer Advisors, Inc. Royalty Pharma PLC Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$26.26 - $29.9 $355,507 - $404,786	13,538 Added 59.34%	36,353 $958,000
Q1 2024 May 10, 2024	BUY	$27.46 - $31.33 $400,311 - $456,728	14,578 Added 176.98%	22,815 $692,000
Q4 2023 Jan 16, 2024	BUY	$26.21 - $29.22 $109,479 - $122,051	4,177 Added 102.88%	8,237 $231,000
Q3 2023 Nov 13, 2023	BUY	$26.26 - $31.38 $106,615 - $127,402	4,060 New	4,060 $110,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.